Dec 12, 2019
*** This is a test sample for GLOBE NEWSWIRE quarterly results release style. It will need to be removed before the site is set to live. *** Second quarter revenue increased to $11.6 million compared to $4.6 million in the same period last year. Received a strategic investment of $100 million from
Dec 03, 2019
*** This is a test sample for PRNewswire quarterly results release style. It will need to be removed before the site is set to live. *** DIVISIONR (valbenazine) Second Quarter Net Product Sales of $96.9 Million with Approximately 16,700 TRx DIVISION? (elagolix), the First FDA-Approved Oral